Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Short Course or Primer
-
Mar 05, 2021
Drug and Medical Device Ad Promo Primer
Learn more
Program Committee
-
Micheline Awad, MBA • Senior Director, Regulatory Affairs - Advertising, Promotions, and Labeling
Turning Point Therapeutics, Inc., A Bristol Myers Squibb Company, United States -
Kimberly Belsky, MS • Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States -
Carla Brooks, MSc, RAC • Senior Director, Regulatory Affairs, Advertising and Promotion
Blueprint Medicines Corporation, United States -
Dale Cooke, JD, MA • President
PhillyCooke Consulting , United States -
Virginia Foley • Head of Marketing & Strategic Business Development Ad Promo - Practice Leader
Opus Regulatory Inc, United States -
Catherine Gray, PharmD • Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States -
Joanne Hawana, JD, MS • Member
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States -
Mary L Raber Johnson, PhD, RAC • Assistant Professor - Clinical
The Ohio State University, College of Pharmacy, United States -
Kevin Madagan, JD • Partner
Reed Smith, LLP, United States -
Sheetal Patel, PharmD • Vice President, Specialty Compliance
Johnson & Johnson, United States -
Victoria Tamarkin, MS • Founding Partner & President, Global Regulatory Affairs, Promotional Compliance
Victoria Tamarkin Consulting LLC, United States -
Mark Gaydos • Vice President & Global Head, Advertising, Promotion & Labeling
Sanofi, United States -
Wayne Pines • President, Health Care
APCO Worldwide Inc., United States -
Lucy Rose, MBA • President
Lucy Rose and Associates, United States